Retrophin Inc. (RTRX): Scopia Capital Adds To Its Stake

Page 2 of 12 – SEC Filing


CUSIP
No.      761299106                

  1. 

NAME OF
REPORTING PERSONS:

Scopia Capital Management LP

  2.

CHECK THE APPROPRIATE BOX IF A MEMBER
OF A GROUP (SEE INSTRUCTIONS)

(a)  ¨        (b)  ¨

  3.

SEC USE ONLY

  4.

CITIZENSHIP OR PLACE OF
ORGANIZATION

Delaware

NUMBER OF SHARES
BENEFICIALLY OWNED BY EACH REPORTING PERSON

WITH

5. 

SOLE VOTING POWER

0

6.

SHARED VOTING POWER

3,811,821

7.

SOLE DISPOSITIVE POWER

0

8.

SHARED DISPOSITIVE POWER

3,811,821

  9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

3,811,821

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN
ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

¨

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT
IN ROW (9)

10.4%

12.

TYPE OF REPORTING PERSON (SEE
INSTRUCTIONS)

PN, IA

Follow Travere Therapeutics Inc. (NASDAQ:TVTX)